Vilon: What It Is, What the Research Shows, and Is It Legal?

Vilon is one of the smallest molecules anyone has ever tried to sell you as an anti-ageing breakthrough. That's not a criticism — it's the most interesting thing about it, and it's also the reason to be sceptical. Here's the honest picture.

What Vilon actually is

Vilon is a dipeptide — a chain of exactly two amino acids joined together. The two are lysine and glutamic acid, so scientists usually call it KE or Lys-Glu rather than by its brand name. For scale: a protein like collagen has over a thousand amino acids. Vilon has two. It is a genuinely tiny molecule.

It came from Vladimir Khavinson's group at the St Petersburg Institute of Bioregulation and Gerontology. Their original work extracted peptide mixtures from animal organs — Thymalin came from the thymus gland. Vilon is what happened next: the team argued that a specific two-amino-acid fragment, KE, was the active part of the thymus extract, and could be made synthetically instead. So Vilon is best understood as the synthetic distillate of Thymalin's supposed active ingredient.

The claim, and why it raises eyebrows

The Khavinson theory is that these ultra-short peptides slip into cells, bind directly to DNA, and switch specific genes on or off — effectively re-tuning an aged cell back toward youthful behaviour. If true, that would be remarkable.

It's worth being upfront about why mainstream biologists are cautious. A two-amino-acid peptide is a very small, very simple thing to be doing something so precise. Your gut breaks proteins down into fragments exactly like this all day long. The claim isn't impossible — short peptides can be transported into cells, and the lab has published work on the mechanism — but an extraordinary claim needs strong independent evidence, and that's the part that's missing.

What it's studied for

• Immune function, especially the age-related decline in T-cells
• Cell ageing — genes like SIRT1 and PARP that are linked to how cells age
• Skin ageing, including collagen production in skin cells
• Inflammation

What the evidence really shows

Vilon's evidence base has a very distinctive shape, and once you see it you can't unsee it: it is almost entirely cells in dishes, and it is almost entirely one research group.

The published studies show KE changing gene expression in human stem cells grown in culture, altering how chromatin (the packaging DNA is wound around) is arranged in cells from elderly donors, and reducing inflammatory signals in immune cell lines. These are real experiments in real journals. Some involve Italian and Georgian collaborators, which is a genuine step up from purely in-house work.

But notice what's not there: there is no body of large, independent, randomised human trials showing that Vilon does anything for a living person. For a compound first described decades ago, that absence is itself informative. Promising things usually get tested properly — unless nobody with the resources and independence to do it thinks the case is strong enough.

The honest bottom line

Vilon is an interesting scientific hypothesis that has spent decades not being properly tested in humans, and is now sold as if it were a finished product. The gap between "KE changes SIRT1 expression in cultured stem cells" and "Vilon will make you age slower" is enormous, and the marketing is built entirely inside that gap. If ageing or immunity is a real concern for you, a doctor is a better use of your money.

What this does not mean